Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Amortizatization of Intangibles (2023 - 2025)

Historic Amortizatization of Intangibles for Lexaria Bioscience (LEXX) over the last 4 years, with Q4 2025 value amounting to $1937.0.

  • Lexaria Bioscience's Amortizatization of Intangibles fell 2097.1% to $1937.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $8533.0, marking a year-over-year decrease of 577.52%. This contributed to the annual value of $9047.0 for FY2025, which is 3559.65% up from last year.
  • Per Lexaria Bioscience's latest filing, its Amortizatization of Intangibles stood at $1937.0 for Q4 2025, which was down 2097.1% from $2070.0 recorded in Q3 2025.
  • In the past 5 years, Lexaria Bioscience's Amortizatization of Intangibles registered a high of $2773.0 during Q1 2024, and its lowest value of $67.0 during Q4 2023.
  • For the 3-year period, Lexaria Bioscience's Amortizatization of Intangibles averaged around $1961.8, with its median value being $2199.0 (2025).
  • In the last 5 years, Lexaria Bioscience's Amortizatization of Intangibles skyrocketed by 355820.9% in 2024 and then tumbled by 2097.1% in 2025.
  • Lexaria Bioscience's Amortizatization of Intangibles (Quarter) stood at $67.0 in 2023, then surged by 3558.21% to $2451.0 in 2024, then decreased by 20.97% to $1937.0 in 2025.
  • Its Amortizatization of Intangibles was $1937.0 in Q4 2025, compared to $2070.0 in Q3 2025 and $2199.0 in Q2 2025.